0
     

Report Added
Report already added
Cancer Immunotherapies Market, Global Outlook and Forecast 2022-2028

Cancer Immunotherapies Market, Global Outlook and Forecast 2022-2028

Cancer immunotherapy, also called biologic therapy, which can predominantly be classed as a form of targeted therapy, It is designed to stimulate the body's immune system to attack tumours.
This report contains market size and forecasts of Cancer Immunotherapies in global, including the following market information:

Global Cancer Immunotherapies Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cancer Immunotherapies Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Cancer Immunotherapies companies in 2021 (%)
The global Cancer Immunotherapies market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Monoclonal Antibodies (MABs) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cancer Immunotherapies include Amgen, AstraZeneca, Roche, Bristol-Myers Squibb, Bayer, Merck, ARMO BioSciences (Eli Lilly), Novartis and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cancer Immunotherapies manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:
Global Cancer Immunotherapies Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cancer Immunotherapies Market Segment Percentages, by Type, 2021 (%)
Monoclonal Antibodies (MABs)
Cancer Vaccines
Immunomodulators
Adoptive Cell transfer
Checkpoint Inhibitors
Global Cancer Immunotherapies Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cancer Immunotherapies Market Segment Percentages, by Application, 2021 (%)
Breast Cancer
Leukemia
Lymphoma
Melanoma
Colorectal Cancer
Non-Small Cell Lung Cancer
Global Cancer Immunotherapies Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cancer Immunotherapies Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cancer Immunotherapies revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cancer Immunotherapies revenues share in global market, 2021 (%)
Key companies Cancer Immunotherapies sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Cancer Immunotherapies sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
AstraZeneca
Roche
Bristol-Myers Squibb
Bayer
Merck
ARMO BioSciences (Eli Lilly)
Novartis
Pfizer
Johnson & Johnson
AbbVie
Gilead Sciences
Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Cancer Immunotherapies Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Immunotherapies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Immunotherapies Overall Market Size
2.1 Global Cancer Immunotherapies Market Size: 2021 VS 2028
2.2 Global Cancer Immunotherapies Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Cancer Immunotherapies Sales: 2017-2028
3 Company Landscape
3.1 Top Cancer Immunotherapies Players in Global Market
3.2 Top Global Cancer Immunotherapies Companies Ranked by Revenue
3.3 Global Cancer Immunotherapies Revenue by Companies
3.4 Global Cancer Immunotherapies Sales by Companies
3.5 Global Cancer Immunotherapies Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Cancer Immunotherapies Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Cancer Immunotherapies Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cancer Immunotherapies Players in Global Market
3.8.1 List of Global Tier 1 Cancer Immunotherapies Companies
3.8.2 List of Global Tier 2 and Tier 3 Cancer Immunotherapies Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Immunotherapies Market Size Markets, 2021 & 2028
4.1.2 Monoclonal Antibodies (MABs)
4.1.3 Cancer Vaccines
4.1.4 Immunomodulators
4.1.5 Adoptive Cell transfer
4.1.6 Checkpoint Inhibitors
4.2 By Type - Global Cancer Immunotherapies Revenue & Forecasts
4.2.1 By Type - Global Cancer Immunotherapies Revenue, 2017-2022
4.2.2 By Type - Global Cancer Immunotherapies Revenue, 2023-2028
4.2.3 By Type - Global Cancer Immunotherapies Revenue Market Share, 2017-2028
4.3 By Type - Global Cancer Immunotherapies Sales & Forecasts
4.3.1 By Type - Global Cancer Immunotherapies Sales, 2017-2022
4.3.2 By Type - Global Cancer Immunotherapies Sales, 2023-2028
4.3.3 By Type - Global Cancer Immunotherapies Sales Market Share, 2017-2028
4.4 By Type - Global Cancer Immunotherapies Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Cancer Immunotherapies Market Size, 2021 & 2028
5.1.2 Breast Cancer
5.1.3 Leukemia
5.1.4 Lymphoma
5.1.5 Melanoma
5.1.6 Colorectal Cancer
5.1.7 Non-Small Cell Lung Cancer
5.2 By Application - Global Cancer Immunotherapies Revenue & Forecasts
5.2.1 By Application - Global Cancer Immunotherapies Revenue, 2017-2022
5.2.2 By Application - Global Cancer Immunotherapies Revenue, 2023-2028
5.2.3 By Application - Global Cancer Immunotherapies Revenue Market Share, 2017-2028
5.3 By Application - Global Cancer Immunotherapies Sales & Forecasts
5.3.1 By Application - Global Cancer Immunotherapies Sales, 2017-2022
5.3.2 By Application - Global Cancer Immunotherapies Sales, 2023-2028
5.3.3 By Application - Global Cancer Immunotherapies Sales Market Share, 2017-2028
5.4 By Application - Global Cancer Immunotherapies Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Cancer Immunotherapies Market Size, 2021 & 2028
6.2 By Region - Global Cancer Immunotherapies Revenue & Forecasts
6.2.1 By Region - Global Cancer Immunotherapies Revenue, 2017-2022
6.2.2 By Region - Global Cancer Immunotherapies Revenue, 2023-2028
6.2.3 By Region - Global Cancer Immunotherapies Revenue Market Share, 2017-2028
6.3 By Region - Global Cancer Immunotherapies Sales & Forecasts
6.3.1 By Region - Global Cancer Immunotherapies Sales, 2017-2022
6.3.2 By Region - Global Cancer Immunotherapies Sales, 2023-2028
6.3.3 By Region - Global Cancer Immunotherapies Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Cancer Immunotherapies Revenue, 2017-2028
6.4.2 By Country - North America Cancer Immunotherapies Sales, 2017-2028
6.4.3 US Cancer Immunotherapies Market Size, 2017-2028
6.4.4 Canada Cancer Immunotherapies Market Size, 2017-2028
6.4.5 Mexico Cancer Immunotherapies Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Cancer Immunotherapies Revenue, 2017-2028
6.5.2 By Country - Europe Cancer Immunotherapies Sales, 2017-2028
6.5.3 Germany Cancer Immunotherapies Market Size, 2017-2028
6.5.4 France Cancer Immunotherapies Market Size, 2017-2028
6.5.5 U.K. Cancer Immunotherapies Market Size, 2017-2028
6.5.6 Italy Cancer Immunotherapies Market Size, 2017-2028
6.5.7 Russia Cancer Immunotherapies Market Size, 2017-2028
6.5.8 Nordic Countries Cancer Immunotherapies Market Size, 2017-2028
6.5.9 Benelux Cancer Immunotherapies Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Cancer Immunotherapies Revenue, 2017-2028
6.6.2 By Region - Asia Cancer Immunotherapies Sales, 2017-2028
6.6.3 China Cancer Immunotherapies Market Size, 2017-2028
6.6.4 Japan Cancer Immunotherapies Market Size, 2017-2028
6.6.5 South Korea Cancer Immunotherapies Market Size, 2017-2028
6.6.6 Southeast Asia Cancer Immunotherapies Market Size, 2017-2028
6.6.7 India Cancer Immunotherapies Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Cancer Immunotherapies Revenue, 2017-2028
6.7.2 By Country - South America Cancer Immunotherapies Sales, 2017-2028
6.7.3 Brazil Cancer Immunotherapies Market Size, 2017-2028
6.7.4 Argentina Cancer Immunotherapies Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Cancer Immunotherapies Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Cancer Immunotherapies Sales, 2017-2028
6.8.3 Turkey Cancer Immunotherapies Market Size, 2017-2028
6.8.4 Israel Cancer Immunotherapies Market Size, 2017-2028
6.8.5 Saudi Arabia Cancer Immunotherapies Market Size, 2017-2028
6.8.6 UAE Cancer Immunotherapies Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Amgen
7.1.1 Amgen Corporate Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Cancer Immunotherapies Major Product Offerings
7.1.4 Amgen Cancer Immunotherapies Sales and Revenue in Global (2017-2022)
7.1.5 Amgen Key News
7.2 AstraZeneca
7.2.1 AstraZeneca Corporate Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Cancer Immunotherapies Major Product Offerings
7.2.4 AstraZeneca Cancer Immunotherapies Sales and Revenue in Global (2017-2022)
7.2.5 AstraZeneca Key News
7.3 Roche
7.3.1 Roche Corporate Summary
7.3.2 Roche Business Overview
7.3.3 Roche Cancer Immunotherapies Major Product Offerings
7.3.4 Roche Cancer Immunotherapies Sales and Revenue in Global (2017-2022)
7.3.5 Roche Key News
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Corporate Summary
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb Cancer Immunotherapies Major Product Offerings
7.4.4 Bristol-Myers Squibb Cancer Immunotherapies Sales and Revenue in Global (2017-2022)
7.4.5 Bristol-Myers Squibb Key News
7.5 Bayer
7.5.1 Bayer Corporate Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer Cancer Immunotherapies Major Product Offerings
7.5.4 Bayer Cancer Immunotherapies Sales and Revenue in Global (2017-2022)
7.5.5 Bayer Key News
7.6 Merck
7.6.1 Merck Corporate Summary
7.6.2 Merck Business Overview
7.6.3 Merck Cancer Immunotherapies Major Product Offerings
7.6.4 Merck Cancer Immunotherapies Sales and Revenue in Global (2017-2022)
7.6.5 Merck Key News
7.7 ARMO BioSciences (Eli Lilly)
7.7.1 ARMO BioSciences (Eli Lilly) Corporate Summary
7.7.2 ARMO BioSciences (Eli Lilly) Business Overview
7.7.3 ARMO BioSciences (Eli Lilly) Cancer Immunotherapies Major Product Offerings
7.7.4 ARMO BioSciences (Eli Lilly) Cancer Immunotherapies Sales and Revenue in Global (2017-2022)
7.7.5 ARMO BioSciences (Eli Lilly) Key News
7.8 Novartis
7.8.1 Novartis Corporate Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Cancer Immunotherapies Major Product Offerings
7.8.4 Novartis Cancer Immunotherapies Sales and Revenue in Global (2017-2022)
7.8.5 Novartis Key News
7.9 Pfizer
7.9.1 Pfizer Corporate Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Cancer Immunotherapies Major Product Offerings
7.9.4 Pfizer Cancer Immunotherapies Sales and Revenue in Global (2017-2022)
7.9.5 Pfizer Key News
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Corporate Summary
7.10.2 Johnson & Johnson Business Overview
7.10.3 Johnson & Johnson Cancer Immunotherapies Major Product Offerings
7.10.4 Johnson & Johnson Cancer Immunotherapies Sales and Revenue in Global (2017-2022)
7.10.5 Johnson & Johnson Key News
7.11 AbbVie
7.11.1 AbbVie Corporate Summary
7.11.2 AbbVie Cancer Immunotherapies Business Overview
7.11.3 AbbVie Cancer Immunotherapies Major Product Offerings
7.11.4 AbbVie Cancer Immunotherapies Sales and Revenue in Global (2017-2022)
7.11.5 AbbVie Key News
7.12 Gilead Sciences
7.12.1 Gilead Sciences Corporate Summary
7.12.2 Gilead Sciences Cancer Immunotherapies Business Overview
7.12.3 Gilead Sciences Cancer Immunotherapies Major Product Offerings
7.12.4 Gilead Sciences Cancer Immunotherapies Sales and Revenue in Global (2017-2022)
7.12.5 Gilead Sciences Key News
8 Global Cancer Immunotherapies Production Capacity, Analysis
8.1 Global Cancer Immunotherapies Production Capacity, 2017-2028
8.2 Cancer Immunotherapies Production Capacity of Key Manufacturers in Global Market
8.3 Global Cancer Immunotherapies Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Cancer Immunotherapies Supply Chain Analysis
10.1 Cancer Immunotherapies Industry Value Chain
10.2 Cancer Immunotherapies Upstream Market
10.3 Cancer Immunotherapies Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Cancer Immunotherapies Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Cancer Immunotherapies in Global Market
Table 2. Top Cancer Immunotherapies Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Cancer Immunotherapies Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Cancer Immunotherapies Revenue Share by Companies, 2017-2022
Table 5. Global Cancer Immunotherapies Sales by Companies, (K Units), 2017-2022
Table 6. Global Cancer Immunotherapies Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Cancer Immunotherapies Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Cancer Immunotherapies Product Type
Table 9. List of Global Tier 1 Cancer Immunotherapies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Immunotherapies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cancer Immunotherapies Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Cancer Immunotherapies Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Cancer Immunotherapies Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Cancer Immunotherapies Sales (K Units), 2017-2022
Table 15. By Type - Global Cancer Immunotherapies Sales (K Units), 2023-2028
Table 16. By Application – Global Cancer Immunotherapies Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Cancer Immunotherapies Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Cancer Immunotherapies Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Cancer Immunotherapies Sales (K Units), 2017-2022
Table 20. By Application - Global Cancer Immunotherapies Sales (K Units), 2023-2028
Table 21. By Region – Global Cancer Immunotherapies Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Cancer Immunotherapies Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Cancer Immunotherapies Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Cancer Immunotherapies Sales (K Units), 2017-2022
Table 25. By Region - Global Cancer Immunotherapies Sales (K Units), 2023-2028
Table 26. By Country - North America Cancer Immunotherapies Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Cancer Immunotherapies Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Cancer Immunotherapies Sales, (K Units), 2017-2022
Table 29. By Country - North America Cancer Immunotherapies Sales, (K Units), 2023-2028
Table 30. By Country - Europe Cancer Immunotherapies Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Cancer Immunotherapies Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Cancer Immunotherapies Sales, (K Units), 2017-2022
Table 33. By Country - Europe Cancer Immunotherapies Sales, (K Units), 2023-2028
Table 34. By Region - Asia Cancer Immunotherapies Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Cancer Immunotherapies Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Cancer Immunotherapies Sales, (K Units), 2017-2022
Table 37. By Region - Asia Cancer Immunotherapies Sales, (K Units), 2023-2028
Table 38. By Country - South America Cancer Immunotherapies Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Cancer Immunotherapies Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Cancer Immunotherapies Sales, (K Units), 2017-2022
Table 41. By Country - South America Cancer Immunotherapies Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Cancer Immunotherapies Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Cancer Immunotherapies Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Cancer Immunotherapies Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Cancer Immunotherapies Sales, (K Units), 2023-2028
Table 46. Amgen Corporate Summary
Table 47. Amgen Cancer Immunotherapies Product Offerings
Table 48. Amgen Cancer Immunotherapies Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. AstraZeneca Corporate Summary
Table 50. AstraZeneca Cancer Immunotherapies Product Offerings
Table 51. AstraZeneca Cancer Immunotherapies Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Roche Corporate Summary
Table 53. Roche Cancer Immunotherapies Product Offerings
Table 54. Roche Cancer Immunotherapies Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Bristol-Myers Squibb Corporate Summary
Table 56. Bristol-Myers Squibb Cancer Immunotherapies Product Offerings
Table 57. Bristol-Myers Squibb Cancer Immunotherapies Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Bayer Corporate Summary
Table 59. Bayer Cancer Immunotherapies Product Offerings
Table 60. Bayer Cancer Immunotherapies Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Merck Corporate Summary
Table 62. Merck Cancer Immunotherapies Product Offerings
Table 63. Merck Cancer Immunotherapies Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. ARMO BioSciences (Eli Lilly) Corporate Summary
Table 65. ARMO BioSciences (Eli Lilly) Cancer Immunotherapies Product Offerings
Table 66. ARMO BioSciences (Eli Lilly) Cancer Immunotherapies Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Novartis Corporate Summary
Table 68. Novartis Cancer Immunotherapies Product Offerings
Table 69. Novartis Cancer Immunotherapies Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Pfizer Corporate Summary
Table 71. Pfizer Cancer Immunotherapies Product Offerings
Table 72. Pfizer Cancer Immunotherapies Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Johnson & Johnson Corporate Summary
Table 74. Johnson & Johnson Cancer Immunotherapies Product Offerings
Table 75. Johnson & Johnson Cancer Immunotherapies Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. AbbVie Corporate Summary
Table 77. AbbVie Cancer Immunotherapies Product Offerings
Table 78. AbbVie Cancer Immunotherapies Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Gilead Sciences Corporate Summary
Table 80. Gilead Sciences Cancer Immunotherapies Product Offerings
Table 81. Gilead Sciences Cancer Immunotherapies Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. Cancer Immunotherapies Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 83. Global Cancer Immunotherapies Capacity Market Share of Key Manufacturers, 2020-2022
Table 84. Global Cancer Immunotherapies Production by Region, 2017-2022 (K Units)
Table 85. Global Cancer Immunotherapies Production by Region, 2023-2028 (K Units)
Table 86. Cancer Immunotherapies Market Opportunities & Trends in Global Market
Table 87. Cancer Immunotherapies Market Drivers in Global Market
Table 88. Cancer Immunotherapies Market Restraints in Global Market
Table 89. Cancer Immunotherapies Raw Materials
Table 90. Cancer Immunotherapies Raw Materials Suppliers in Global Market
Table 91. Typical Cancer Immunotherapies Downstream
Table 92. Cancer Immunotherapies Downstream Clients in Global Market
Table 93. Cancer Immunotherapies Distributors and Sales Agents in Global Market

List of Figures
Figure 1. Cancer Immunotherapies Segment by Type
Figure 2. Cancer Immunotherapies Segment by Application
Figure 3. Global Cancer Immunotherapies Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cancer Immunotherapies Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cancer Immunotherapies Revenue, 2017-2028 (US$, Mn)
Figure 7. Cancer Immunotherapies Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Cancer Immunotherapies Revenue in 2021
Figure 9. By Type - Global Cancer Immunotherapies Sales Market Share, 2017-2028
Figure 10. By Type - Global Cancer Immunotherapies Revenue Market Share, 2017-2028
Figure 11. By Type - Global Cancer Immunotherapies Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Cancer Immunotherapies Sales Market Share, 2017-2028
Figure 13. By Application - Global Cancer Immunotherapies Revenue Market Share, 2017-2028
Figure 14. By Application - Global Cancer Immunotherapies Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Cancer Immunotherapies Sales Market Share, 2017-2028
Figure 16. By Region - Global Cancer Immunotherapies Revenue Market Share, 2017-2028
Figure 17. By Country - North America Cancer Immunotherapies Revenue Market Share, 2017-2028
Figure 18. By Country - North America Cancer Immunotherapies Sales Market Share, 2017-2028
Figure 19. US Cancer Immunotherapies Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Cancer Immunotherapies Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Cancer Immunotherapies Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Cancer Immunotherapies Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Cancer Immunotherapies Sales Market Share, 2017-2028
Figure 24. Germany Cancer Immunotherapies Revenue, (US$, Mn), 2017-2028
Figure 25. France Cancer Immunotherapies Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Cancer Immunotherapies Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Cancer Immunotherapies Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Cancer Immunotherapies Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Cancer Immunotherapies Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Cancer Immunotherapies Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Cancer Immunotherapies Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Cancer Immunotherapies Sales Market Share, 2017-2028
Figure 33. China Cancer Immunotherapies Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Cancer Immunotherapies Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Cancer Immunotherapies Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Cancer Immunotherapies Revenue, (US$, Mn), 2017-2028
Figure 37. India Cancer Immunotherapies Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Cancer Immunotherapies Revenue Market Share, 2017-2028
Figure 39. By Country - South America Cancer Immunotherapies Sales Market Share, 2017-2028
Figure 40. Brazil Cancer Immunotherapies Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Cancer Immunotherapies Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Cancer Immunotherapies Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Cancer Immunotherapies Sales Market Share, 2017-2028
Figure 44. Turkey Cancer Immunotherapies Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Cancer Immunotherapies Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Cancer Immunotherapies Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Cancer Immunotherapies Revenue, (US$, Mn), 2017-2028
Figure 48. Global Cancer Immunotherapies Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Cancer Immunotherapies by Region, 2021 VS 2028
Figure 50. Cancer Immunotherapies Industry Value Chain
Figure 51. Marketing Channels

Report Title: Cancer Immunotherapies Market, Global Outlook and Forecast 2022-2028


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

US Transdermal Patch Market Opportunity & Clinical Trials Insight 2028

US Transdermal Patch Market Opportunity & Clinical Trials Insight 2028

Asia Pacific Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

Asia Pacific Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

Europe Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

Europe Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

North America Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

North America Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

Global Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Region: Trend Forecast and Growth Opportunity

Global Single Cell Multiomics Market 2021-2031 by Product Type (Instruments, Consumables, Software), Omics Type (SCG, SCT, SCP, SCM), Application (Clinical Research, Translation Research, Synthetic Biology), Sample Type (Human, Animal, Microbial), Workflow (Single-Cell Isolation and Dispensing, Single-Cell Analysis), End User (Research and Academic Laboratories, Biopharma and Biotech Companies, CROs, Others), and Region: Trend Forecast and Growth Opportunity

Asia Pacific Rehabilitation Equipment Market 2021-2031 by Product (Daily Living Aids, Exercise Equipment, Body Support Devices, Mobility Equipment), Application (Physiotherapy, Occupational Therapy, Others), End User (Hospitals & Clinics, Rehab Centers, Homecare Settings, Physiotherapy Centers, Others), and Country: Trend Forecast and Growth Opportunity

Asia Pacific Rehabilitation Equipment Market 2021-2031 by Product (Daily Living Aids, Exercise Equipment, Body Support Devices, Mobility Equipment), Application (Physiotherapy, Occupational Therapy, Others), End User (Hospitals & Clinics, Rehab Centers, Homecare Settings, Physiotherapy Centers, Others), and Country: Trend Forecast and Growth Opportunity